YM-46303 is an antagonist of mAChR
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 8-10 weeks | $ 1023 | |
10 mg | 8-10 weeks | $ 1943 | |
20 mg | 8-10 weeks | $ 2761 | |
50 mg | 8-10 weeks | $ 6091 | |
100 mg | 8-10 weeks | $ 9623 |
Description | YM-46303 is an antagonist of mAChR |
In vivo | Compared with oxybutynin, YM-46303 showed about 10 times higher inhibitory activity on bladder pressure during reflex rhythmic contractions, and increased selectivity of bladder contraction about saliva secretion in rats by about 5 times. Further evaluation of antimuscarinic effects on bradycardia and pressor in pithed rats, and on tremor in mice, show that YM-46303 can be useful for the treatment of urinary urge incontinence as a bladder-selective M3 antagonist with potent activities and fewer side effects. YM-46303 shows in vivo selective inhibitory activities on bladder pressure in reflexly-evoked rhythmic contraction against oxotremorine-induced salivary secretion. In addition, YM-46303 has potent activity in a guinea pig model of methacholine-induced bronchospasm on intravenous administration. |
CAS No. | 171722-81-9 |
Chemical Formula | C20H23ClN2O2 |
Molecular Weight | 358.87 |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom